Case Studies in Myeloproliferative Neoplasms

Experts in MPN review clinical cases of in polycythemia vera, myelofibrosis, and essential thrombocythemia.

EP. 1: Case 1: Hydroxyurea-Resistant Polycythemia Vera (P. Vera)

April 30th 2021

Prithviraj Bose, MD, reviews the case of a 57-year-old man diagnosed with polycythemia vera.

EP. 2: Case 1: Diagnosis of P. Vera

April 30th 2021

Experts in MPN discuss diagnostic considerations for polycythemia vera.

EP. 3: Case 1: Risk Assessment in P. Vera

April 30th 2021

Dr. Ruben Mesa and panel discuss the importance of and methods for risk assessment in patients with polycythemia vera.

EP. 4: Case 1: Initial Treatment Options for Low Risk P. Vera

April 30th 2021

Jamile Shammo, MD, reviews initial treatment options for patients with low risk polycythemia vera.

EP. 5: Case 1: Considerations for Cytoreductive Therapy in P. Vera

May 7th 2021

Experts in polycythemia vera discuss decision-making around when to initiate cytoreductive therapy in patients with low risk polycythemia vera.

EP. 6: Case 1: Treatment Options after Hydroxyurea Failure in P. Vera

May 7th 2021

Dr Prithviraj Bose reviews treatment options in the setting of hydroxyurea failure in patients with polycythemia vera.

EP. 7: Case 1: Treatment Approaches for High Risk P. Vera

May 14th 2021

Prithviraj Bose, MD, and colleagues discuss treatment options for high risk polycythemia vera.

EP. 8: Case 1: Role of Symptomatic Improvement in Overall Outcome in MF

May 14th 2021

Experts in polycythemia vera review data regarding the role of symptomatic improvement in overall outcome in patients with polycythemia vera.

EP. 9: Case 2: High Risk Myelofibrosis (MF)

May 20th 2021

Dr Jamile Shammo reviews the case of a 72-year-old man with primary myelofibrosis.

EP. 10: Case 2: Prognostic Models of MF

May 20th 2021

Jamile Shammo, MD, reviews prognostic models in myelofibrosis.